Clinical trial Recruiting at 1 site Interventional Ages 18 to 90

Using patients' own cells to treat osteoarthritis

Official title: Adipose-Derived Biocellular Regenerative Therapy in Treatment of Osteoarthritis (OA) and Associated Connective Tissue Degeneration and Pain

Run by Healeon Medical Inc · NCT04238143 · Data updated 2026-11-12

This study is testing whether using patients' own stem cells and platelet-rich plasma can help treat osteoarthritis better than traditional methods.

Quick facts

Study typeInterventional
Ages18 Years to 90 Years
SexAll
Enrollment100 (estimated)
SponsorHealeon Medical Inc
Industry-sponsored
Drugs / interventionschemotherapy, radiation
Locations2 sites (Valencia, California and 1 other locations)
StatusRecruiting
StartedJanuary 10, 2020
Main results expectedSeptember 30, 2026
Study endsSeptember 30, 2027
Registry record updatedOctober 1, 2024
Trial IDNCT04238143 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals with documented osteoarthritic changes in joints such as the knee, hip, or shoulder, who are able to tolerate the procedures.

Probably not a fit

Patients with systemic disorders, active cancer, or those who are pregnant may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the use of autologous stem/stromal cells combined with high-dose platelet-rich plasma (HD-PRP) to treat osteoarthritis (OA) through minimally invasive methods. It aims to address the limitations of traditional surgical interventions and medical management by employing biocellular and cellular therapies. Participants will undergo various treatment approaches, including guided biocellular therapy and systemic deployment of cellular stromal vascular fraction (cSVF), with their progress tracked over time. The study will document baseline findings and evaluate the safety and effectiveness of these innovative treatments.

Why it matters

Potential benefit: If successful, this approach could provide a long-term, minimally invasive treatment option for patients suffering from osteoarthritis.

How similar studies have gone: Other studies have shown promise with similar biocellular approaches, but this specific methodology is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Documented osteoarthritic inflammatory and/or degenerative changes in the joint or connective tissues of the knee, hip, shoulder, Achilles tendon, Sacroiliac Joint, wrist/hand, foot/ankle, or Plantar Fasciitis (PR);
* No systemic disorders which, in opinion of principal investigator, would disqualify from safely being able to undergo the determined procedures;
* Have the ability to understand and accept all items in Informed Consent Document;
* Have adequate perivascular and extracellular matrix donor tissues available;
* Mature enough to tolerate determined procedures and follow up instructions and complete post-treatment tracking responsibilities

Exclusion Criteria:

* Systemic or psychological impairment which would preclude patient tolerance and understanding nature and extent of procedures and follow up tracking;
* Known active cancer, chemotherapy, or radiation therapy;
* Pregnancy;
* Active infections which would increase risk of patient to undergo treatment;
* High dose steroid users, or recipients of corticosteroids with a six month period before treatment date;
* Medication or Opiate addition, or in active treatment for drug rehabilitation;
* History of documented severe traumatic brain injuries;
* In the opinion of the principal investigator/provider, the patient's condition or medical issues which would not allow the individual to fully accomplish or complete the study requirements

Where it's running

  • Hemwall Center for Orthopedic Regenerative Medicine
    Valencia, California, United States
    Recruiting
  • Regenevita LLC
    Stevensville, Montana, United States
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • Arthrosamid versus steroid injections for managing knee osteoarthritis.

    This trial will test whether a single Arthrosamid hydrogel injection works better than a standard steroid plus local anesthetic injection for adults with symptomatic knee osteoarthritis.

    Recruiting Phase 4 Cappagh National Orthopaedic Hospital · Dublin, Dublin · NCT07489521

  • Choose to Move Replacement Ready for people waiting for hip or knee replacement

    This project will test whether the Choose to Move Replacement Ready program helps older adults on hip or knee replacement waitlists increase physical activity, improve mobility, and support psychosocial health.

    Recruiting University of British Columbia · Vancouver, British Columbia · NCT07069179

  • Evaluating OA-SYS for knee osteoarthritis treatment

    This study is testing a new treatment called OA-SYS using adult stem cells to see if it can help people with moderate to severe knee osteoarthritis feel better and improve their knee function.

    Recruiting Phase 2 Ageless Biotech, Inc. · Las Vegas, Nevada · NCT06485843

  • Targeting abnormal blood flow to treat chronic joint pain in veterans

    This study is testing if treating abnormal blood flow in the joints can help veterans with chronic pain and osteoarthritis feel better.

    Recruiting Palo Alto Veterans Institute for Research · Palo Alto, California · NCT05700682

  • Low-impact exercise program for joint pain relief

    This study is testing if joining low-impact exercise classes can help people with knee, hip, and ankle pain from osteoarthritis feel better and move easier.

    Recruiting University of Missouri-Columbia · Columbia, Missouri · NCT03711773

  • Autologous adipose-derived stem cell injections for knee osteoarthritis

    We’re testing whether injecting a patient’s own fat-derived stem cells into the knee can help people with knee OA feel less pain and move better, compared with a standard hyaluronic acid treatment.

    Recruiting at 3 sites Yonsei University · Incheon and 2 other locations · NCT07901790

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.